...
首页> 外文期刊>BMC Molecular Biology >A novel, non-radioactive eukaryotic in vitro transcription assay for sensitive quantification of RNA polymerase II activity
【24h】

A novel, non-radioactive eukaryotic in vitro transcription assay for sensitive quantification of RNA polymerase II activity

机译:一种新颖的非放射性真核体外转录测定法,用于RNA聚合酶II活性的灵敏定量

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Many studies of the eukaryotic transcription mechanism and its regulation rely on in vitro assays. Conventional RNA polymerase II transcription assays are based on radioactive labelling of the newly synthesized RNA. Due to the inefficient in vitro transcription, the detection of the RNA involving purification and gel electrophoresis is laborious and not always quantitative. Herein, we describe a new, non-radioactive, robust and reproducible eukaryotic in vitro transcription assay that has been established in our laboratory. Upon transcription, the newly synthesized RNA is directly detected and quantified using the QuantiGene assay. Alternatively, the RNA can be purified and a primer extension followed by PCR detection or qPCR quantification can be performed. When applied to assess the activity of RNA polymerase II inhibitors, this new method allowed an accurate estimation of their relative potency. Our novel assay provides a non-radioactive alternative to a standard in vitro transcription assay that allows for sensitive detection and precise quantification of the newly transcribed, unlabelled RNA and is particularly useful for quantification of strong transcriptional inhibitors like α-amanitin. Moreover, the method can be easily adapted to quantify the reaction yield and the transcription efficiency of other eukaryotic in vitro systems, thus providing a complementary tool for the field of transcriptional research.
机译:真核转录机制及其调控的许多研究都依赖于体外测定。常规的RNA聚合酶II转录测定是基于新合成RNA的放射性标记。由于体外转录效率低下,因此涉及纯化和凝胶电泳的RNA检测很费力,而且并不总是定量的。在这里,我们描述了一种新的,非放射性的,健壮的和可再现的真核体外转录测定方法,该方法已在我们的实验室中建立。转录后,可以使用QuantiGene测定法直接检测和定量新合成的RNA。或者,可以纯化RNA,并可以进行引物延伸,然后进行PCR检测或qPCR定量。当用于评估RNA聚合酶II抑制剂的活性时,这种新方法可以准确估计其相对效力。我们的新颖测定法提供了一种非放射性替代标准体外转录测定法的方法,该方法可对新转录的未标记RNA进行灵敏的检测和精确定量,特别适用于定量强转录抑制剂(如α-amanitin)。而且,该方法可以容易地适用于定量其他真核生物体外系统的反应产率和转录效率,从而为转录研究领域提供了补充工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号